Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism

Overview of attention for article published in Breast Cancer Research and Treatment, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 2 X users

patent: 3 patents

Citations

dimensions_citation: 98 Dimensions

Readers on

mendeley: 73 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

SMAC MIMETICS FOR USE IN THE TREATMENT OF PERSISTENT HIV INFECTION

Application EP-3682873-A1

European Patent Office

Use of disulfiram for inflammatory breast cancer therapy

Grant US-10195164-B2

United States of America

THERAPEUTIC IAP ANTAGONISTS FOR TREATING PROLIFERATIVE DISORDERS

Application WO-2016097773-A1

World Intellectual Property Organisation (WIPO)